A Sweden-based biotechnology company has signed a license to use human embryonic stem cells discovered at the University of Wisconsin-Madison.
Cellartis AB said the agreement with the Wisconsin Alumni Research Foundation opens the door to the U.S. market for its stem cell-related products. The company is focused on using the cells and related products in drug discovery and regenerative medicine.